It’s that time a year again when I make the rounds to raise money for a cure for cancer. As I may have mentioned in the past, my cancer, multiple myeloma, is diagnosed in over 30,000 new patients each year.
When I was diagnosed in October of 2014, the life expectancy for a level 3 sufferer like myself was 29 months. That was 96 months ago!
I am very grateful that my life has been extended. I can attribute this wonderful gift directly to contributions like yours. Since my diagnosis, 10 new medications have been developed AND approved by the FDA. There is an effort now to CURE multiple myeloma for future patients. I could never have believed this statement if you had asked me 8 years ago. Truly remarkable. It has come through efforts of many people including from your contributions.
I have done my very best not to waste this gift of time.
This year, my oncologist, Dr. Adrianna Rossi and I are again teaming up to direct your very thoughtful contributions to Mt Sinai – chimeric antigen receptor T cell (CAR-T) research .
Mt Sinai’s reputation goes before it. Chimeric antigen receptor T cell therapy is a cutting-edge tool for modifying one’s own T cell to have your own immune system fight the cancer. Your dollars are making a difference. I am living proof of that fact. You may make your donation by clicking on the “Donate Now” button.
Check donations can be made:
Made out to: Mount Sinai Health System
Memo: Support CAR-T Research
Attn: Natasha McCabe
Mount Sinai Health System
One Gustave L. Levy Place, Box 1049
New York, NY 10029
Please include Andrew Larew and Chrissy Wojcik’s name with the donation.
For those committing $100 or more in an annual pledge, Chrissy and I plan to invite you to a luncheon at the Metropolitan Museum of Art this fall. We expect that one or more of our PA’s or NP’s to fill you in on recent developments during the luncheon.
For the top 4 pledges, we will be inviting those lucky individuals for a luncheon at The Modern. Our favorite Michelin starred restaurant in midtown. My oncologist, and team captain, Dr. Adrianna Rossi, will be pleased to update you on chimeric antigen receptor T cell and other developments in cancer research and treatment during this luncheon.
We are very proud to be part of the answer to this difficult diagnosis and hope you can join us in our efforts to find a treatment and a cure. We look forward to your feedback. Thank you for your participation.
Andrew E. Larew & Chrissy Wojcik
Larew, Doyle & Associates, LLC
190 E 72nd Street, Ste 15A
New York, NY 10021